Literature DB >> 28107855

A close look at an integrative treatment package for Bell's palsy in Korea.

Seung Min Kathy Lee1, Suji Lee2, Jun Hyeong Park3, Jongbae J Park4, Sanghoon Lee5.   

Abstract

OBJECTIVE: To provide an overview of the integrative treatment package for Bell's palsy provided at Kyung Hee University Korean Medicine Hospital (KHU KMH).
SUMMARY: The Facial Palsy Center at KHU KMH has been providing integrative treatment for Bell's palsy patients during the past three decades. Within 72 h of symptom onset, corticosteroids are recommended but complementary treatment including acupuncture and herbal medicine can be used to help suppress inflammation and nerve degeneration. If patients suffer from postauricular pain, pharmacopuncture and cupping is utilized. During the subacute or chronic periods, different acupuncture types are selected accordingly, and herbal medicine and moxibustion helps to improve immune functions and relieve accessory symptoms. Qigong programs are also provided to help relieve facial tension and paralysis.
CONCLUSIONS: Although rigorous research is warranted, with limited treatment options, we highly suggest that it is worth applying integrative medicine to Bell's palsy patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acupuncture; Bell's palsy; Integrative treatment; Korean medicine

Mesh:

Year:  2016        PMID: 28107855     DOI: 10.1016/j.ctcp.2016.12.003

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  2 in total

1.  Distribution of Medical Service Use for Facial Palsy Between Medicine and Traditional Korean Medicine Based on Population-Based Data of Korea.

Authors:  Junhui Jeong; So Ra Yoon; Hyunsun Lim; Hyun Seung Choi
Journal:  J Korean Med Sci       Date:  2022-04-18       Impact factor: 5.354

2.  A spadework for integrative medicine based critical pathways for facial palsy: Web-based survey from traditional Korean medicine doctors.

Authors:  Jung-Hyun Kim; Bonhyuk Goo; Sang-Soo Nam
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.